title: Commentary on "New directions for frontotemporal dementia drug discovery." Do we know enough to develop meaningful treatments for frontotemporal dementia?
authors.affiliation: Elan Pharmaceuticals, South San Francisco, CA, USA. dale.schenk@elan.com
authors.forename: Dale
authors.initials: D
authors.lastname: Schenk
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D003704:Dementia / Q000188:drug therapy*; D015195:Drug Design; D006801:Humans; D012107:Research Design